Moreover, we found that SAHA treatment results in a significant reduction of HDAC7, a principle HDAC that mediates correction of NPC141, as well as other protein misfolding diseases such as cystic fibrosis38,46 and alpha-1 antitrypsin deficiency39,40,47. Here, HDAC7 is linked to proteostasis deficiencies.